NCT00161655View on ClinicalTrials.gov

Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

December 31, 2006

Conditions
PsoriasisArthritis, Psoriatic
Interventions
DRUG

Etanercept

DRUG

Methotrexate

Trial Locations (8)

Unknown

Fredriksberg Alle

Gentofte Amtsygehus

Helsinki

Tampere

Rikshospitalet

Hudlegekontoret Akutten

Lakarhuset Fasta Centrum

Lakarhuset

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00161655 - Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis | Biotech Hunter | Biotech Hunter